In addition to the mRNA reduction of classical breast cancer subtype markers, expression of ERBB receptor family members HER3 and HER4, as well as the major ligands associated with all major ERBB family signaling molecules (EGF, BTC, HRG) were reduced (Supplemental Fig. 1A). This evidence concerns the gene BTC and breast cancer.